InvestorsHub Logo

RG

Followers 634
Posts 95666
Boards Moderated 3
Alias Born 06/12/2004

RG

Re: None

Monday, 04/12/2010 9:16:13 AM

Monday, April 12, 2010 9:16:13 AM

Post# of 2071
Sunridge International to Present at FSX Conference in San Francisco, CA
Date : 04/12/2010 @ 9:00AM
Source : PR Newswire
Stock : Sunridge Intl (BB) (SNDZ)
Quote : 0.37 0.0 (0.00%) @ 2:05AM


Sunridge International to Present at FSX Conference in San Francisco, CA

Sunridge International to Present at FSX Conference in San Francisco, CA

PR Newswire

FOUNTAIN HILLS, Ariz., April 12

FOUNTAIN HILLS, Ariz., April 12 /PRNewswire-FirstCall/ --

Sunridge International, (OTC Bulletin Board: SNDZ) will be presenting at the upcoming FSX (Financial Services Exchange, Inc.) investors conference being held in San Francisco, CA on April 29-May 1, 2010.

Sunridge International's CEO, G. Richard Smith, said, "Our marketing outreach program over the past two months has been a great success in gaining awareness throughout the U.S. investment community. This upcoming FSX Conference will allow us to continue to further our efforts to communicate the progress that Sunridge has made in recent months and the inroads it has made in several of the world's major markets."

About FSX

FSX hosts quarterly investment conferences around the country, providing opportunities for networking and one-on-one communication between independent broker/dealers and companies seeking exposure or funding. FSX is the oldest, most established U.S. forum for independent broker/dealers, and has raised over $1.5 billion for its presenters in the past 24 years. FSX conferences also provide a forum for direct investment programs, mutual funds, and asset management companies. For more information visit: www.fsxone.com.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International (www.oi-pnt.com).

For full details of PNT and its application, we invite you to visit Sunridge International's website at www.sunridgeint.com.

CONTACT: